These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 25953004)

  • 21. Trends in the use of lipid-lowering drugs by outpatients with diabetes in Taiwan, 1997-2003.
    Chiang CW; Chiu HF; Chen CY; Wu HL; Yang CY
    Pharmacoepidemiol Drug Saf; 2008 Jan; 17(1):62-9. PubMed ID: 17924453
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discontinuation of blood pressure-lowering, glucose-lowering, and lipid-lowering medications after bariatric surgery in patients with morbid obesity: a nationwide cohort study in South Korea.
    Jeon SM; Kwon Y; Kim D; Hwang J; Heo Y; Park S; Kwon JW
    Surg Obes Relat Dis; 2024 Sep; 20(9):840-848. PubMed ID: 38631926
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diffusion into use of exenatide for glucose control in diabetes mellitus: a retrospective cohort study of a new therapy.
    Segal JB; Dy SM; Millman EA; Herbert R; Bass EB; Wu A
    Clin Ther; 2007 Aug; 29(8):1784-94. PubMed ID: 17919559
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Persistence of use of lipid-lowering medications: a cross-national study.
    Avorn J; Monette J; Lacour A; Bohn RL; Monane M; Mogun H; LeLorier J
    JAMA; 1998 May; 279(18):1458-62. PubMed ID: 9600480
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors associated with statin selection among privately insured commercial and Medicare patients.
    Zhao Z; Bae J; Sponseller CA; Zhu Y; Kryzhanovski VA; LeNarz LA
    Curr Med Res Opin; 2013 Apr; 29(4):395-404. PubMed ID: 23406054
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increase in lipid-lowering treatment rates among TRICARE beneficiaries: a population-based study.
    Devine J; Linton A; Mistry H; Napier J; Trice S; Bacon T
    Pharmacoepidemiol Drug Saf; 2009 Oct; 18(10):891-9. PubMed ID: 19634117
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Suboptimal management of cardiovascular risk factors in coronary heart disease patients in primary care occurs particularly in women.
    Driscoll A; Beauchamp A; Lyubomirsky G; Demos L; McNeil J; Tonkin A
    Intern Med J; 2011 Oct; 41(10):730-6. PubMed ID: 21627740
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence and coexistence of cardiovascular comorbidities among the US dyslipidemic population aged ≥ 65 years by lipid-lowering medication use status.
    Candrilli SD; Kuznik A; Mendys PM; Wilson DJ
    Postgrad Med; 2010 Sep; 122(5):142-9. PubMed ID: 20861598
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of antihypertensive, antidiabetic, and dyslipidemic prescription medication use among children and adolescents.
    Liberman JN; Berger JE; Lewis M
    Arch Pediatr Adolesc Med; 2009 Apr; 163(4):357-64. PubMed ID: 19349565
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A retrospective analysis of the prevalence and treatment of hypertension and dyslipidemia in Southwestern Ontario, Canada.
    Petrella RJ; Merikle E
    Clin Ther; 2008 Jun; 30(6):1145-54. PubMed ID: 18640470
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Dyslipidemia - when are lipid lowering medications useful in clinical practice?].
    Blum MR; Stanga Z; Rodondi N
    Praxis (Bern 1994); 2013 May; 102(10):585-9. PubMed ID: 23644243
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regional variations in ambulatory care and incidence of cardiovascular events.
    Tu JV; Chu A; Maclagan L; Austin PC; Johnston S; Ko DT; Cheung I; Atzema CL; Booth GL; Bhatia RS; Lee DS; Jackevicius CA; Kapral MK; Tu K; Wijeysundera HC; Alter DA; Udell JA; Manuel DG; Mondal P; Hogg W;
    CMAJ; 2017 Apr; 189(13):E494-E501. PubMed ID: 28385894
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Familial hypercholesterolemia and estimation of US patients eligible for low-density lipoprotein apheresis after maximally tolerated lipid-lowering therapy.
    Vishwanath R; Hemphill LC
    J Clin Lipidol; 2014; 8(1):18-28. PubMed ID: 24528684
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of lipid-lowering treatment in cardiovascular disease prevalence in familial hypercholesterolemia.
    Perez-Calahorra S; Laclaustra M; Marco-Benedí V; Lamiquiz-Moneo I; Pedro-Botet J; Plana N; Sanchez-Hernandez RM; Amor AJ; Almagro F; Fuentes F; Suarez-Tembra M; Civeira F;
    Atherosclerosis; 2019 May; 284():245-252. PubMed ID: 30827715
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Underuse of ACE inhibitors and angiotensin II receptor blockers in elderly patients with diabetes.
    Winkelmayer WC; Fischer MA; Schneeweiss S; Wang PS; Levin R; Avorn J
    Am J Kidney Dis; 2005 Dec; 46(6):1080-7. PubMed ID: 16310574
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gonadal steroids, gonadotropins and DHEAS in young adults with familial hypercholesterolemia who had initiated statin therapy in childhood.
    Braamskamp MJ; Kusters DM; Wiegman A; Avis HJ; Wijburg FA; Kastelein JJ; van Trotsenburg AS; Hutten BA
    Atherosclerosis; 2015 Aug; 241(2):427-32. PubMed ID: 26079405
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patient characteristics and prescription fill patterns for allergic rhinitis medications, with a focus on montelukast, in a commercially insured population.
    Bollinger ME; Diette GB; Chang CL; Stephenson JJ; Sajjan SG; Fan T; Allen-Ramey FC
    Clin Ther; 2010 Jun; 32(6):1093-102. PubMed ID: 20637964
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Attainment of LDL-Cholesterol Treatment Goals in Patients With Familial Hypercholesterolemia: 5-Year SAFEHEART Registry Follow-Up.
    Perez de Isla L; Alonso R; Watts GF; Mata N; Saltijeral Cerezo A; Muñiz O; Fuentes F; Diaz-Diaz JL; de Andrés R; Zambón D; Rubio-Marin P; Barba-Romero MA; Saenz P; Sanchez Muñoz-Torrero JF; Martinez-Faedo C; Miramontes-Gonzalez JP; Badimón L; Mata P;
    J Am Coll Cardiol; 2016 Mar; 67(11):1278-85. PubMed ID: 26988947
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Are high-risk hypertensive patients being prescribed concomitant statin therapy?: a retrospective cohort study.
    Chapman RH; Petrilla AA; Berman L; Benner JS; Tang SS
    Am J Cardiovasc Drugs; 2009; 9(5):299-308. PubMed ID: 19791839
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipid-lowering agents.
    Ewang-Emukowhate M; Wierzbicki AS
    J Cardiovasc Pharmacol Ther; 2013 Sep; 18(5):401-11. PubMed ID: 23811423
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.